menu
    • menu

    Company profile for Palvella Therapeutics

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Palvella is a biopharmaceutical company committed to serving patients with debilitating rare, genetic diseases through the development and commercialization of life-changing, pathogenetically targeted therapies. The company was founded with the single-minded goal of serving individuals suffering from rare diseases by developing safe and efficacious therapies that will dramatically enhance their quality of life. The Palvella t...
    Palvella is a biopharmaceutical company committed to serving patients with debilitating rare, genetic diseases through the development and commercialization of life-changing, pathogenetically targeted therapies. The company was founded with the single-minded goal of serving individuals suffering from rare diseases by developing safe and efficacious therapies that will dramatically enhance their quality of life. The Palvella team is committed to recruiting passionate and like-minded collaborators to ensure we expeditiously deliver on this important mission for rare disease patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Palvella TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    125 Strafford Avenue Suite #360 Wayne, PA 19087
    Telephone
    Telephone
    484-253-1460
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://palvellatx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Palvella Pharma Uplists To Nasdaq Global Market
    Palvella Pharma Uplists To Nasdaq Global Market

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293886/0/en/palvella-therapeutics-announces-uplisting-to-the-nasdaq-global-market.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Palvella Initiates Phase2 For QTORIN Rapamycin for Angiokeratomas
    Palvella Initiates Phase2 For QTORIN Rapamycin for Angiokeratomas

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286595/0/en/palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant-angiokeratomas.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Palvella Pharma Hosts Q1 2026 Update Call May 7
    Palvella Pharma Hosts Q1 2026 Update Call May 7

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284733/0/en/palvella-therapeutics-to-host-first-quarter-2026-financial-results-and-corporate-update-conference-call-on-may-7-2026.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Palvella Therapeutics Appoints John D. Doux, MD, MBA, to Board
    Palvella Therapeutics Appoints John D. Doux, MD, MBA, to Board

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272389/0/en/Palvella-Therapeutics-Appoints-John-D-Doux-M-D-M-B-A-Dermatologist-and-Recognized-Leader-in-Rare-Skin-Diseases-to-Board-of-Directors.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share
    Palvella Appoints Kent Taylor as Senior Vice President of Sales
    Palvella Appoints Kent Taylor as Senior Vice President of Sales

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269001/0/en/Palvella-Therapeutics-Appoints-Accomplished-Commercial-Leader-Kent-Taylor-as-Senior-Vice-President-of-Sales.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Palvella Pharma Reveals 2025 Financials And Corporate Update
    Palvella Pharma Reveals 2025 Financials And Corporate Update

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265348/0/en/Palvella-Therapeutics-Reports-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search